Synthesis and Studies of Furo[2,3-c]pyrans
1
diastereomer: M.p. 139 °C; [α]3D0 = +42.93 (c = 0.909, CHCl3). H
Compound 10j: Following the general procedure, dimethyl malonate
NMR: δ = 2.15 (s, 3 H), 2.40 (s, 3 H), 3.17–3.21 (m, 1 H), 3.53 (s, (0.25 mL, 2.16 mmol) was treated with 7 (0.40 g, 1.35 mmol) in the
1 H), 3.54 (s, 3 H), 3.60 (d, J = 9.6 Hz, 1 H), 3.87 (dd, J = 3.2,
9.2 Hz, 1 H), 4.19–4.20 (m, 2 H), 5.00 (d, J = 2.8 Hz, 1 H), 5.07
(d, J = 8.8 Hz, 1 H), 7.24 (d, J = 8.0 Hz, 2 H), 7.46–7.50 (m, 2 H),
7.61–7.66 (m, 3 H), 7.88 (d, J = 7.6 Hz, 2 H) ppm. 13C NMR: δ =
21.6, 30.6, 37.9, 55.4, 61.2, 61.5, 67.0 (CH2), 67.3, 99.6, 128.8,
129.0, 129.5ϫ 2, 134.1, 134.2 (C), 136.6 (C), 144.9 (C), 194.2 (C),
presence of tBuOK (0.18 g, 1.62 mmol) for 3 h to give 10j (0.54 g,
93%) as a white crystalline solid, m.p. 98 °C; [α]3D0 = +25.7 (c =
1.23, CHCl3). 1H NMR: δ = 2.43 (s, 3 H), 2.98–3.06 (m, 1 H), 3.47
(s, 3 H), 3.50 (d, J = 9.6 Hz, 1 H), 3.75 (s, 3 H), 3.78 (s, 3 H), 3.80–
3.88 (m, 4 H), 4.09–4.11 (m, 1 H), 4.86 (d, J = 3.0 Hz, 1 H), 7.39
(d, J = 8.0 Hz, 2 H), 7.82 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR: δ
201.5 (C). HRMS (ES): calcd. for C24H26O7SNa [M + Na]+ = 21.7, 36.4, 52.5, 52.7, 53.2, 55.3, 60.0, 65.3, 66.8 (CH2), 67.2,
481.1285; found 481.1297.
99.3, 129.7, 129.8, 133.9 (C), 145.2 (C), 168.0 (C), 168.2 (C) ppm.
HRMS (ES): calcd. for C19H24O9SNa [M + Na]+ 451.1045; found
451.1039.
Compound 10f: Following the general procedure, 1,3-cyclohexane-
dione (0.15 g, 1.35 mmol) was treated with 7 (0.25 g, 0.85 mmol) in
the presence of tBuOK (0.11 g,1.01 mmol) for 22 h to give 10f
(0.32 g, 93%) as a white glassy crystalline solid, m.p. 162 °C; [α]3D0
= +78.6 (c = 1.16, CHCl3). 1H NMR: δ = 1.75–1.78 (m, 1 H), 2.09–
2.35 (m, 4 H), 2.39 (s, 3 H), 3.55 (s, 3 H), 3.65 (d, J = 9.2 Hz, 2
H), 3.85–3.88 (m, 2 H), 4.06 (d, J = 8.4 Hz, 1 H), 4.52 (s, 1 H),
5.18 (d, J = 1.2 Hz, 1 H), 7.28 (d, J = 8.0 Hz, 2 H), 7.77 (d, J =
8.4 Hz, 2 H), 9.33 (s, 1 H) ppm. 13C NMR: δ = 19.6 (CH2), 21.6,
29.9 (CH2), 32.4, 36.0 (CH2), 57.0, 61.7, 66.3, 68.6 (CH2), 73.0,
101.4, 114.0 (C), 129.2, 129.7, 134.7 (C), 144.7 (C), 173.6 (C), 196.9
(C) ppm. HRMS (ES): calcd. for C20H24O7SNa [M + Na]+
431.1124; found 431.1140.
General Procedure for the Conversion of 10a–g into 11a–g: Com-
pounds 10a–g were treated with TFA (2 equiv) for 3–28 h at ambi-
ent temperature. After completion of the reaction (TLC), the reac-
tion mixture was poured into satd. aq. NaHCO3 (30 mL), then par-
titioned between aq. NaHCO3 and EtOAc (3ϫ 20 mL). Organic
extracts were pooled, dried with anhyd. Na2SO4 and filtered. The
filtrate was stirred for 0.5 h with Et3N and the mixture was evapo-
rated to dryness under reduced pressure. The resulting residue was
purified by column chromatography over silica gel to give the pure
product.
Compound 11a: Following the general procedure, in 3 h, 10a
(0.30 g, 0.75 mmol) was converted into 11a (0.13 g, 80%) as a col-
Compound 10g: Following the general procedure, dimedone (0.30 g,
2.16 mmol) was treated with 7 (0.40 g, 1.35 mmol) in the presence
of tBuOK (0.18 g, 1.62 mmol) for 20 h to give 10g (0.21 g, 96%) as
a white crystalline solid, m.p. 74 °C; [α]3D0 = +24.0 (c = 0.95,
CHCl3). 1H NMR: δ = 0.95 (s, 3 H), 1.02 (s, 3 H), 2.17 (d, J =
2.4 Hz, 2 H), 2.25 (d, J = 17.6 Hz, 1 H), 2.35 (d, J = 17.6 Hz, 1
H), 2.41 (s, 3 H), 3.43 (d, J = 9.2 Hz, 1 H), 3.57 (s, 3 H), 3.75 (d,
J = 8.4 Hz, 1 H), 3.82 (d, J = 12 Hz, 2 H), 4.03 (d, J = 8.4 Hz, 1
H), 4.47 (s, 1 H), 5.16 (d, J = 1.6 Hz, 1 H), 7.32 (d, J = 8.4 Hz, 2
H), 7.89 (d, J = 8.4 Hz, 2 H), 9.35 (s, 1 H) ppm. 13C NMR: δ =
21.6, 26.8, 29.2, 31.0, 32.3, 43.7 (CH2), 49.9 (CH2), 57.0, 62.2, 66.8,
68.6 (CH2), 73.0, 101.5, 113.1 (C), 129.3, 130.2, 134.2 (C), 144.8
orless jelly. [α]3D0 = +25.4 (c = 1.27, CHCl3). H NMR: δ = 2.24 (s,
1
3 H), 2.32 (s, 3 H), 3.95–4.00 (m, 2 H), 4.42 (dd, J = 2.4, 12.8 Hz,
1 H), 4.88–4.92 (m, 1 H), 6.23 (d, J = 3.6 Hz, 1 H), 9.12 (s, 1 H)
ppm. 13C NMR: δ = 15.7, 29.2, 38.7 (CH), 65.1 (CH2), 79.3 (CH),
117.6 (C), 123.3 (CH), 152.2 (C), 168.1 (C), 186.6 (CH), 193.1 (C)
ppm. HRMS (ES): calcd. for C11H13O4 [M + H]+ 209.0794; found
209.0814.
Compound 11b: Following the general procedure, in 16 h, com-
pound 10b (0.16 g, 0.40 mmol) was converted into a 11b (0.06 g,
71%) as a colorless jelly. [α]3D0 = +20.9 (c = 0.47, CHCl3). 1H NMR:
δ = 2.19 (s, 3 H), 3.78 (s, 3 H), 3.88–3.90 (m, 1 H), 3.99 (d, J =
(C), 172.0 (C), 196.9 (C) ppm. HRMS (ES): calcd. for C22H29O7S 3.2 Hz, 1 H), 4.39 (dd, J = 2.4, 12.8 Hz, 1 H), 4.93–4.95 (m, 1 H),
[M + H]+ 437.1626; found 437.1634.
6.20 (d, J = 3.6 Hz, 1 H), 9.17 (s, 1 H) ppm. 13C NMR: δ = 14.3,
38.0, 51.2, 65.1 (CH2), 79.2, 105.3 (C), 122.8, 152.2 (C), 165.4 (C),
169.4 (C), 186.5 ppm. HRMS (ES): calcd. for C11H13O5 [M + H]+
225.0770; found 225.0763.
Compound 10h: Following the general procedure, nitromethane
(0.12 mL, 2.16 mmol) was treated with 7 (0.40 g, 1.35 mmol) in the
presence of tBuOK (0.18 g, 1.62 mmol) for 4 h to give 10h (0.44 g,
92%) as a white crystalline solid, m.p. 128 °C; [α]3D0 = +11.9 (c =
1.47, CHCl3). 1H NMR: δ = 2.45 (s, 3 H), 3.10–3.14 (m, 1 H),
3.28–3.29 (m, 1 H), 3.41 (s, 3 H), 3.58 (d, J = 9.6 Hz, 1 H), 3.89
(dd, J = 3.2, 9.6 Hz, 1 H), 4.01 (s, 1 H), 4.10 (s, 1 H), 4.25 (dd, J
= 4.0, 13.6 Hz, 1 H), 4.68–4.74 (m, 1 H), 4.94 (d, J = 2.8 Hz, 1 H),
7.38 (d, J = 8.0 Hz, 2 H), 7.83 (d, J = 8.0 Hz, 2 H) ppm. 13C NMR:
δ = 21.7, 35.4, 55.4, 59.6, 64.5, 65.9, 66.5 (CH2), 74.8 (CH2), 99.0,
129.2, 130.1, 133.6 (C), 145.7 (C) ppm. HRMS (ES): calcd. for
C15H19NO7SNa [M + Na]+ 380.0800; found 380.0780.
Compound 11c: Following the general procedure, in 20 h, com-
pound 10c (0.16 g, 0.40 mmol) was converted into 11c (0.06 g,
75%) as a colorless jelly. [α]3D0 = –11.3 (c = 2.53, CHCl3). 1H NMR:
δ = 1.16–1.30 (m, 3 H), 2.14 (d, J = 1.2 Hz, 3 H), 3.82–3.91 (m, 2
H), 4.08–4.22 (m, 2 H), 4.33 (dd, J = 2.8, 12.6 Hz, 1 H), 4.85–4.92
(m, 1 H), 6.15 (dd, J = 0.6, 3.8 Hz, 1 H), 9.11 (s, 1 H) ppm. 13C
NMR: δ = 14.5ϫ 2, 38.2, 60.1 (CH2), 65.3 (CH2), 79.3, 105.7 (C),
122.9, 152.4 (C), 165.2 (C), 169.2 (C), 186.5. HRMS (ES): calcd.
for C12H14O4Na [M + Na]+ 245.0793; found 245.0789.
Compound 11d: Following the general procedure, in 9 h, compound
10d (0.15 g, 0.35 mmol) was converted into 11d (0.06 g, 85%) as a
Compound 10i: Following the general procedure, malononitrile
(0.14 mL, 2.16 mmol) was treated with 7 (0.40 g, 1.35 mmol) in the
presence of tBuOK (0.18 g, 1.62 mmol) for 1.5 h to give 10i (0.46 g,
colorless jelly. [α]3D0 = +18.6 (c = 0.64, CHCl3). H NMR: δ = 2.19
1
(d, J = 0.4 Hz, 3 H), 3.02 (s, 3 H), 4.00–4.04 (m, 2 H), 4.41 (dd, J
= 2.8, 12.8 Hz, 2 H), 5.00–5.03 (m, 1 H), 6.24 (d, J = 3.6 Hz, 1 H),
9.21 (s, 1 H) ppm. 13C NMR: δ = 13.5, 38.7, 45.2, 64.8 (CH2), 79.5,
112.7 (C), 120.5, 152.7 (C), 168.3 (C), 186.1 ppm. HRMS (ES):
calcd. for C10H12O5SNa [M + Na]+ 267.0301; found 267.0303.
95%) as a white crystalline solid compound, m.p. 135 °C; [α]3D0
=
1
+16.9 (c = 10.27, CHCl3). H NMR: δ = 2.45 (s, 3 H), 3.02–3.06
(m, 1 H), 3.42 (s, 3 H), 3.52–3.53 (m, 1 H), 3.91 (d, J = 9.6 Hz, 1
H), 4.00 (dd, J = 3.2, 10.0 Hz, 1 H), 4.09–4.10 (m, 1 H), 4.25 (s, 1
H), 4.40 (d, J = 10.0 Hz, 1 H), 4.97 (d, J = 2.8 Hz, 1 H), 7.39 (d,
J = 8.0 Hz, 2 H), 7.85 (d, J = 8.0 Hz, 2 H) ppm. 13C NMR: δ = Compound 11e: Following the general procedure, in 28 h, com-
21.8, 24.8, 38.2, 56.1, 60.1, 64.3, 65.8 (CH2), 66.1, 99.3, 110.7 (C),
111.1 (C), 130.0, 130.1, 133.5 (C), 146.2 (C) ppm. HRMS (ES):
calcd. for C17H19N2O5S [M + H]+ 363.1006; found 363.1014.
pound 10e (0.24 g, 0.51 mmol) was converted into 11e (0.11 g,
76%) as a colorless jelly. [α]3D0 = +17.5 (c = 1.26, CHCl3). 1H NMR:
δ = 1.70 (s, 3 H), 4.05 (d, J = 12.4 Hz, 1 H), 4.16 (d, J = 8.4 Hz, 1
Eur. J. Org. Chem. 2013, 8197–8207
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
8205